Products Affected - Description
Multivitamins with A, B, D, E, and K Plus Zinc, Source CF
Pediatric liquid, 60 mL bottle (NDC 68212-0300-60) - discontinued
Chewable tablet, 90 count (NDC 68212-0600-90) - discontinued
Softgel capsule, 60 count (NDC 68212-0500-60) - discontinued
Chewable tablet, 60 count (NDC 44183-0200-60) - discontinued
Reason for the Shortage
- Source CF discontinued all Multivitamins with A, B, D, E and K Plus Zinc presentations in late-2014.
- Axcan Pharma discontinued ADEKs chewable tablets in May 2011.
- Macoven discontinued AKEDamins in early-2014.
- Standard multivitamins are not affected by this shortage.
- Libertas launched softgel capsules in early-July 2014.
Pediatric liquid, 60 mL (NDC 58914-0214-60)
Chewable tablet, 60 count (NDC 58914-0014-60)
Softgel capsule, 60 count (NDC 58914-0011-06)
Multivitamins with A, B, D, E, and K Plus Zinc, Libertas
Chewable tablet, 60 count (NDC 51862-0173-06)
Pediatric liquid, 60 mL (NDC 51862-0166-60)
Softgel capsule, 60 count (NDC 51862-0174-06)
Estimated Resupply Dates
All presentations are available.
October 21, 2014; August 18, 2014; July 3, 2014; June 26, 2014; May 12, 2014; March 20, 2014; January 31, 2014; December 18, 2013; September 25, 2013; July 11, 2013; May 8, 2013; April 2, 2013; March 14, 2013; January 25, 2013, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins